Phase 2 Clinical Trial for CMT1 and CMTX
Acceleron recruited adults with CMT1 and CMTX for a Phase 2 clinical trial studying investigational drug ACE-083.
Thank you for your interest in participating, but the study is fully subscribed and registration is closed.
To learn about other clinical trials you may be eligible for, visit CMTA’s Clinical Trials page.